| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |